The global protein engineering market size accounted for USD 4.35 billion in 2024, grew to USD 5.09 billion in 2025, and is expected to be worth around USD 20.86 billion by 2034, poised to grow at a CAGR of 16.97% between 2024 and 2034. The North America protein engineering market size is predicted to increase from USD 1.78 billion in 2024 and is estimated to grow at the fastest CAGR of 17.11% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Protein Engineering Market
5.1. COVID-19 Landscape: Protein Engineering Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Protein Engineering Market, By Product
8.1. Protein Engineering Market, by Product, 2024-2034
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Software & Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Protein Engineering Market, By Technology
9.1. Protein Engineering Market, by Technology, 2024-2034
9.1.1. Rational Protein Design
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Directed Evolution
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Hybrid Approach
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. De Novo Protein Design
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Protein Engineering Market, By Protein Type
10.1. Protein Engineering Market, by Protein Type, 2024-2034
10.1.1. Others
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Monoclonal Antibodies
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Vaccines
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Colony Stimulating Factor
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Coagulation Factors
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Other Proteins
10.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Protein Engineering Market, By End-User
11.1. Protein Engineering Market, by April, 2024-2034
11.1.1. Academic Research Institutes
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Contract Research Organizations
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Pharmaceutical & Biotechnology Companies
11.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Protein Engineering Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.1.4. Market Revenue and Forecast, by End-User(2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-User(2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.2.4. Market Revenue and Forecast, by End-User(2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-User(2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-User(2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-User(2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.3.4. Market Revenue and Forecast, by End-User(2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-User(2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-User(2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-User(2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.4.4. Market Revenue and Forecast, by End-User(2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-User(2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-User(2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-User(2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-User(2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Protein Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-User(2021-2034)
Chapter 13. Company Profiles
13.1. Amgen, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Agilent Technologies
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Bruker Cor.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PerkinElmer, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Waters Corp.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bio-Rad Laboratories
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Merck KGaA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Danaher Corp.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. GenScript Biotech Corp.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample